Advair Diskus Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
What is Advair Diskus?
Advair diskus is a formulation containing fluticasone propionate and salmeterol xinafoate used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is marketed by GlaxoSmithKline under various trade names including Advair and Seretide (UK).
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
58 patients in the community are taking or have taken Advair Diskus.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 46 | 82% |
| Breathing difficulty | 4 | 7% |
| General health | 4 | 7% |
| Asthma | 2 | 3% |
Dosages
Based on the patients currently taking Advair Diskus.
Duration
How long current patients have been taking Advair Diskus or how long patients were taking Advair Diskus before stopping.
Currently taking Advair Diskus
Stopped taking Advair Diskus
Patient Reported Evaluations
Results from 2 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Major | 100% | 1 |
|---|
Other
Side-effects (as an overall problem)
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 0% | 0 |
| None | 100% | 2 |
Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (1 of 2)
-
- GoodTimes
- Depression: 1
- Emotional: 1
- Compulsion: 0
- Anxiety: 0
- Mania: 0
- Physical: 0
- External Stress: Moderate
- 37 M
- Function: High
- Distress: Low
- See profile
-
by GoodTimes
Aug 19, 2008
- EfficacySlight
- Side-effectsNone
- Asthma
- See full evaluation
-
0 helpful marks